Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Avastin - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Avastin

Approved

STANDARD

Avastin

Roche Diagnostics GmbH🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 404da2f1608d0848
Company: Roche Diagnostics GmbH
Type: Standard

Approval Details

Approval Id: 404da2f1608d0848
Drug Approval Philippines Name: Avastin
Product Name: Avastin
Registration Number: BR-739
Brand Name: Avastin
Generic Name: Bevacizumab
Dosage Form: Concentrate for Solution for Infusion (IV)
Dosage Strength: 400 mg/16 mL (25 mg/mL)
Manufacturer: Roche Diagnostics GmbH
Trader: F.Hoffman-La Roche Ltd.
Importer: Roche (Philippines) Inc.
Distributor: Zuellig Pharma Corporation
Company Detail Path: /organization/roche-diagnostics-gmbh
Trader Detail Path: /organization/f-hoffman-la-roche-ltd
Issuance Date: 25 May 2025
Expiry Date: 09 July 2031
Pharmacologic Category: VEGF/VEGFR (Vascular Endothelial Growth Factor)
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

404da2f1608d0848

Type

Standard

Back to Philippines FDA Approvals